← SynDRA
SEMAGACESTAT
SynDRA canonical compound SYN0011468 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Mechanism of action | gamma secretase inhibitor |
All known targets
- PSEN1
- APH1A
- APH1A; APH1B; NCSTN; PSENEN; PSEN1
- APH1B
- NCSTN
- PSEN2
- PSENEN
Mechanisms of action (all sources)
- APH1A INHIBITOR
- gamma-secretase inhibitor
- PSENEN INHIBITOR
- APH1B INHIBITOR
- PSEN1 INHIBITOR
- NCSTN INHIBITOR
- PSEN2 INHIBITOR
- Modulator
Cross-references
Synonyms
- LY-450139
- LY450139
- DAPT
- AN-37124
- AN-44989
- LY-374973
- LY-411575
- LY-424354
- LY-4501395
- Gamma-secretase inhibitors (Alzheimer's disease), Elan Pharmaceuticals/Eli Lilly
- LY 450139
- 3YN0602W4W
- semagacestatum
- RefChem:931602
- DTXCID40158231
- Semagacestat (LY450139)
- MFCD09970409
- Semagacestat [USAN]
- Semagacestat [USAN:INN]
- Semagacestat?
- UNII-3YN0602W4W
- SEMAGACESTAT [MI]
- Semagacestat (USAN/INN)
- SEMAGACESTAT [INN]
- Semagacestat; LY450139
- MLS006010180
- SCHEMBL417581
- SEMAGACESTAT [WHO-DD]
- GTPL6978
- orb1301052
- SCHEMBL29353755
- BDBM28944
- CHEBI:131158
- PKXWXXPNHIWQHW-RCBQFDQVSA-N
- HMS3884G21
- EX-A2257
- NSC755982
- s1594
- AKOS015924574
Look up SEMAGACESTAT in the interactive SynDRA portal →